DarioHealth Corp (DRIO)

Currency in USD
10.020
-0.520(-4.93%)
Closed·
10.010-0.010(-0.10%)
·

DRIO Earnings

Latest Release
Nov 13, 2025
EPS / Forecast
-2.96 / -0.19
Revenue / Forecast
5.00M / 8.54M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
09/2025-2.96/-0.195M/8.54M-1,457.89%-41.45%Free Sign Up
06/2025-3.54/-0.25.37M/7.12M-1,670%-24.58%Free Sign Up
03/20250.14/-0.16.75M/7.47M+240%-9.64%Free Sign Up
12/2024-0.08/-0.2277.6M/7.51M+64.71%+1.2%Free Sign Up
09/20240.25/-0.227.42M/7.4M+213.64%+0.27%Free Sign Up
06/2024-0.08/-0.456.26M/7.92M+82.22%-20.96%Free Sign Up
03/20240.2/-0.425.76M/5.82M+147.62%-1.03%Free Sign Up
12/2023-0.41/-0.413.6M/3.6M0%0%Free Sign Up
09/20230.49/-0.523.52M/5.42M+194.23%-35.06%Free Sign Up
06/20230.58/-0.56.15M/6.66M+216%-7.66%Free Sign Up

All numbers in USD

DarioHealth Corp Earnings Call Summary for Q3/2025

  • DarioHealth reported Q3 2025 EPS of -2.96 (vs -0.19 forecast) and revenue of $5M (vs $8.54M expected), triggering a 17.87% stock decline to $11.75
  • Despite revenue dropping from $7.4M in Q3 2024, gross margins improved to 60% (from 55% in Q2 2025), showing operational efficiencies amid financial challenges
  • The company aims to reach cash flow breakeven by late 2026/early 2027 and is targeting $12.4M in new business for 2026, focusing on recurring revenue
  • Strategic priorities include expansion into the pharma services market targeting the $10B MASH opportunity and a national rollout with UnitedHealthcare in January 2026
Last Updated: 2025-11-13, 09:54 a/m
Read Full Transcript

FAQ

What Is DarioHealth's Earnings Per Share (TTM)?

The DarioHealth EPS (TTM) is -11.36.

When Is The Next DarioHealth Earnings Date?

DarioHealth will release its next earnings report on Nov 13, 2025.

What Is DarioHealth’s Revenue Forecasts For Upcoming Quarters?

DarioHealth’s revenue forecast is 11.28M.

How Did DarioHealth React to the Company's Latest Earnings Report?

DarioHealth reported a -1,670% EPS surprise and a -24.58% revenue surprise, comparing the latest report against analyst forecasts. The stock price changed by -0.170%, reflecting the market's response to the earnings results.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.